Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.9K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.9K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492
Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and frequency of haematological testing in patients initiating clozapine in the USA.

BMJ mental health·2026
Same author

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same author

Asyndromic surveillance of New York City emergency department diagnoses with the tree-temporal scan statistic.

Journal of public health research·2026
Same author

PEPRVision: a visualization framework for Pharmacoepidemiology research.

American journal of epidemiology·2026
Same author

A Plasmode Simulation-Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information-Rich Subsets.

Pharmacoepidemiology and drug safety·2026
Same author

Sequential Safety Surveillance of RSVpreF Vaccination During Pregnancy Early in the Postapproval Period.

JAMA network open·2026

Related Experiment Video

Updated: May 1, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.2K

Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and

Judith C Maro1, Jeffrey S Brown, Gerald J Dal Pan

  • 1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

Pharmacoepidemiology and Drug Safety
|April 5, 2014
PubMed
Summary

Outcome misclassification in medical product surveillance extends detection times. Careful algorithm selection is crucial for timely safety signal detection in large observational data networks.

Keywords:
adverse drug eventbias (epidemiology)outcome measurement errorpharmacoepidemiologypharmacovigilancepostmarketing product surveillance

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

16.5K

Related Experiment Videos

Last Updated: May 1, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.2K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

16.5K

Area of Science:

  • Pharmacovigilance and Pharmacoepidemiology
  • Health Data Science
  • Biostatistics

Background:

  • Outcome misclassification is a known issue in retrospective epidemiologic studies.
  • Limited understanding exists regarding outcome misclassification in sequential analysis for medical product safety surveillance.
  • The US Food and Drug Administration's Sentinel System plans to use sequential analysis for monitoring medical product risks.

Purpose of the Study:

  • To model and simulate the impact of outcome misclassification on sequential surveillance for medical product safety.
  • To evaluate how different outcome detection algorithms affect surveillance duration and safety signal timeliness.
  • To provide guidance for designing observational data networks that account for outcome misclassification.

Main Methods:

  • Simulated sequential database surveillance using a vaccine safety example.
  • Employed various outcome detection algorithms, characterized by sensitivity and positive predictive value.
  • Calculated the impact of misclassification on surveillance length and signal detection timeliness.

Main Results:

  • Non-differential outcome misclassification significantly increases surveillance time and delays safety signal detection.
  • Algorithms with high sensitivity and low positive predictive value are more effective for detecting rare outcomes.
  • The need for medical chart validation can alter the optimal algorithm choice.

Conclusions:

  • Findings highlight critical considerations for designing pharmacovigilance observational data networks.
  • Tradeoffs exist between using large component databases versus smaller integrated delivery system databases with easier access to clinical data and validation capabilities.